Family Study of Lymphoproliferative Disorders
This observational study is looking into how genetics and environmental factors might lead to blood and lymph node cancers, such as lymphoma and leukemia. Researchers want to understand why these cancers sometimes run in families. You may be able to join if you are between 18 and 100 years old and have at least two living, blood-related family members who have been diagnosed with a lymphoproliferative disorder (a condition where certain white blood cells grow too much). The study aims to measure the ongoing risk of developing blood or lymphoma cancers. The current recruitment status is unclear.
- Study design
- This is an observational study that plans to enroll 3000 participants.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- The primary endpoint, risk of blood or lymphoma, is measured at ongoing.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Family Study of Lymphoproliferative Disorders
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Susan Slager, Ph.D. · PRINCIPAL_INVESTIGATOR · Mayo Clinic
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Risk of blood or lymphomaOngoing